Efficacy and safety of different agents, dosages and strategies of anti‐vascular endothelial growth factor treatment for neovascular age‐related macular degeneration: a network meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of different agents, dosages and strategies of anti‐vascular endothelial growth factor treatment for neovascular age‐related macular degeneration: a network meta‐analysis of randomized controlled trials

Published:2021-01-13 Issue:7 Volume:99 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Zhao Xin‐Yu¹²,Meng Li‐Hui¹²,Liu Sheng‐zhi³,Chen You‐Xin¹²^ORCID

Affiliation:

1. Department of Ophthalmology Peking Union Medical College Hospital Chinese Academy of Medical Sciences Beijing China

2. Key Lab of Ocular Fundus Diseases Chinese Academy of Medical Sciences Beijing China

3. Department of Biomedical Engineering Indiana University Purdue University Indianapolis Indianapolis IN USA

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14756

Reference32 articles.

1. Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of on-demand therapy every 4 or 8 weeks

2. Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

3. Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010

4. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

5. Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials;Eye;2024-09-11

2. Case report: heart failure related to intravitreal injection of anti-VEGF;BMC Cardiovascular Disorders;2024-08-12

3. Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting;Ophthalmology Retina;2023-10

4. Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis;Advances in Therapy;2022-06-09

5. Efficacy and Safety of Anti–Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison;Frontiers in Pharmacology;2021-12-21